BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 24335566)

  • 1. A pilot study on EGFR-targeted molecular imaging of PET/CT With 11C-PD153035 in human gliomas.
    Sun J; Cai L; Zhang K; Zhang A; Pu P; Yang W; Gao S
    Clin Nucl Med; 2014 Jan; 39(1):e20-6. PubMed ID: 24335566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive efficacy of (11)C-PD153035 PET imaging for EGFR-tyrosine kinase inhibitor sensitivity in non-small cell lung cancer patients.
    Dai D; Li XF; Wang J; Liu JJ; Zhu YJ; Zhang Y; Wang Q; Xu WG
    Int J Cancer; 2016 Feb; 138(4):1003-12. PubMed ID: 26334931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular imaging of epidermal growth factor receptor in glioma-bearing rats].
    Wang H; Yu JM; Song XR; Yang GR; Mu DB; Zhao SQ; Wang XW; Wei L; Liu YL; Song B; Fu Z; Teng XP
    Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):343-6. PubMed ID: 18953832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular imaging with 11C-PD153035 PET/CT predicts survival in non-small cell lung cancer treated with EGFR-TKI: a pilot study.
    Meng X; Loo BW; Ma L; Murphy JD; Sun X; Yu J
    J Nucl Med; 2011 Oct; 52(10):1573-9. PubMed ID: 21903741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of epidermal growth factor receptor targeting probe [11C]PD153035: impact on biodistribution and tumor uptake in rats.
    Samén E; Arnberg F; Lu L; Olofsson MH; Tegnebratt T; Thorell JO; Holmin S; Stone-Elander S
    J Nucl Med; 2013 Oct; 54(10):1804-11. PubMed ID: 24003078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further characterization of the epidermal growth factor receptor ligand 11C-PD153035.
    Wang H; Yu JM; Yang GR; Song XR; Sun XR; Zhao SQ; Wang XW; Zhao W
    Chin Med J (Engl); 2007 Jun; 120(11):960-4. PubMed ID: 17624262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and initial tumor affinity testing of iodine-123 labelled EGFR-affine agents as potential imaging probes for hormone-refractory prostate cancer.
    Fozing T; Scheuer C; Samnick S
    Eur J Med Chem; 2010 Sep; 45(9):3780-6. PubMed ID: 20538380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Utility of 11C-methionine PET/CT in neuro-oncology].
    Casas Parera I; Igirio Gamero JL; Blumenkrantz Y; Bruno G; Báez A; Tafur Canabal JG; Báez M; Kuchkaryan V
    Medicina (B Aires); 2013; 73(3):201-6. PubMed ID: 23732194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of 4'-[methyl-(11)C]-thiothymidine uptake with Ki-67 immunohistochemistry and tumor grade in patients with newly diagnosed gliomas in comparison with (11)C-methionine uptake.
    Tanaka K; Yamamoto Y; Maeda Y; Yamamoto H; Kudomi N; Kawai N; Toyohara J; Nishiyama Y
    Ann Nucl Med; 2016 Feb; 30(2):89-96. PubMed ID: 26511019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET-based biodistribution and radiation dosimetry of epidermal growth factor receptor-selective tracer 11C-PD153035 in humans.
    Liu N; Li M; Li X; Meng X; Yang G; Zhao S; Yang Y; Ma L; Fu Z; Yu J
    J Nucl Med; 2009 Feb; 50(2):303-8. PubMed ID: 19164239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors.
    Jacobs AH; Thomas A; Kracht LW; Li H; Dittmar C; Garlip G; Galldiks N; Klein JC; Sobesky J; Hilker R; Vollmar S; Herholz K; Wienhard K; Heiss WD
    J Nucl Med; 2005 Dec; 46(12):1948-58. PubMed ID: 16330557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic and metastatic characteristics of ALK-rearranged lung adenocarcinoma on FDG PET/CT.
    Choi H; Paeng JC; Kim DW; Lee JK; Park CM; Kang KW; Chung JK; Lee DS
    Lung Cancer; 2013 Mar; 79(3):242-7. PubMed ID: 23261227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [PET/CT with 11C-methionine in assessment of brain glioma metabolism].
    Vikhrova NB; Kalaeva DB; Tyurina AN; Belyaev AY; Danilov GV; Pronin IN
    Zh Vopr Neirokhir Im N N Burdenko; 2024; 88(1):63-69. PubMed ID: 38334732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ¹¹C-methionine and ¹⁸F-fluorodeoxyglucose positron emission tomography/CT in the evaluation of patients with suspected primary and residual/recurrent gliomas.
    Li DL; Xu YK; Wang QS; Wu HB; Li HS
    Chin Med J (Engl); 2012 Jan; 125(1):91-6. PubMed ID: 22340472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of whole-body PET/CT and PET/MRI in breast cancer patients: lesion detection and quantitation of 18F-deoxyglucose uptake in lesions and in normal organ tissues.
    Pace L; Nicolai E; Luongo A; Aiello M; Catalano OA; Soricelli A; Salvatore M
    Eur J Radiol; 2014 Feb; 83(2):289-96. PubMed ID: 24331845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy.
    Grosu AL; Weber WA; Franz M; Stärk S; Piert M; Thamm R; Gumprecht H; Schwaiger M; Molls M; Nieder C
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):511-9. PubMed ID: 16168843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of 11C-choline PET/CT for lung cancer diagnosis and the relation between choline metabolism and proliferation of cancer cells.
    Li M; Peng Z; Liu Q; Sun J; Yao S; Liu Q
    Oncol Rep; 2013 Jan; 29(1):205-11. PubMed ID: 23124523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of 11C-labeled-4-N-(3-bromoanilino)-6,7-dimethoxyquinazoline as a positron emission tomography agent to monitor epidermal growth factor receptor expression.
    Wang H; Yu J; Yang G; Song X; Sun X; Zhao S; Mu D
    Cancer Sci; 2007 Sep; 98(9):1413-6. PubMed ID: 17627611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.
    Tsuboyama T; Tatsumi M; Onishi H; Nakamoto A; Kim T; Hori M; Sakane M; Hori Y; Morii E; Hatazawa J; Tomiyama N
    Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3'-deoxy-3'-18F-fluorothymidine PET/CT to guide therapy with epidermal growth factor receptor antagonists and Bcl-xL inhibitors in non-small cell lung cancer.
    Zannetti A; Iommelli F; Speranza A; Salvatore M; Del Vecchio S
    J Nucl Med; 2012 Mar; 53(3):443-50. PubMed ID: 22331221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.